This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Georgia Tech Research Corporation, North Carolina State University, University of Virginia Patent Foundation. Active years: 2019-2022.
Company Filing History:
2 out of 2,190 
1 out of 1,489 
1 out of 1,043 
Years Active: 2019-2022
Title: Innovations of Sarah E Stabenfeldt
Introduction
Sarah E Stabenfeldt is a prominent inventor based in Tempe, AZ (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative microgel technologies. With a total of 2 patents, her work focuses on enhancing clot formation and stability in physiological conditions.
Latest Patents
Stabenfeldt's latest patents include the development of functionalized microgels with fibrin binding elements. These ultra-low crosslinked microgels, also known as Platelet-like Particles (PLPs), are designed with crosslinking densities of less than 0.5%. The polymers used in these microgels are conjugated with a fibrin-binding element, such as H6, which allows for selective binding to fibrin. This innovation enables the microgels to replicate key functions of platelets, including binding, stabilizing, and enhancing fibrin clot formation. Additionally, the PLPs respond to injury cues and induce clot contraction, making them a valuable tool in medical applications.
Career Highlights
Throughout her career, Stabenfeldt has worked with notable organizations, including the Georgia Tech Research Corporation and the University of Virginia Patent Foundation. Her experience in these institutions has allowed her to advance her research and contribute to the field of biomedical innovations.
Collaborations
Some of her notable coworkers include Louis Andrew Lyon and Thomas Harrison Barker. Their collaborative efforts have further enriched the research and development of her patented technologies.
Conclusion
Sarah E Stabenfeldt's innovative work in the field of microgel technology showcases her dedication to advancing biomedical engineering. Her patents reflect her commitment to improving medical outcomes through scientific innovation.